Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 24.79
-2.01 (-7.50%)
At close: Jun 1, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.83 billion as of June 1, 2026. Its market cap has decreased by -3.98% in one year.
Market Cap
9.83B
Enterprise Value
8.87B
Revenue
277.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.79
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.83B, a decrease of -21.22%. That is a compound annual growth rate of -7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 9.83B | -1.62% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 11.64B |
| InventisBio | 11.28B |
| Hualan Biological Vaccine | 10.72B |
| Daan Gene | 9.94B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.43B |
| Chengdu Easton Biopharmaceuticals | 9.25B |
| Vcanbio Cell & Gene Engineering Corp., | 9.07B |
| Liaoning Chengda Biotechnology | 8.83B |